Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study

被引：13
|
作者：
Chuang, Shih-Chieh [1 ,2 ]
Lin, Che-Chen [3 ,4 ]
Peng, Cheng-Yuan [1 ,2 ]
Huang, Wen-Hsin [1 ,2 ]
Su, Wen-Pang [1 ,2 ]
Lai, Shih-Wei [1 ,5 ]
Lai, Hsueh-Chou [2 ,6 ]
机构：
[1] China Med Univ, Sch Med, Taichung, Taiwan
[2] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan
[3] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[4] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan
[5] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan
[6] China Med Univ, Sch Chinese Med, Taichung, Taiwan
来源：
GUT | 2019年 / 68卷 / 07期
关键词：
D O I：
10.1136/gutjnl-2018-316899
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1337 / +
页数：3
相关论文
共 50 条
  • [1] Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study
    Tran-Duy, A.
    Connell, N. J.
    Vanmolkot, F. H.
    Souverein, P. C.
    de Wit, N. J.
    Stehouwer, C. D. A.
    Hoes, A. W.
    de Vries, F.
    de Boer, A.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2019, 285 (02) : 205 - 214
  • [2] Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
    Zipursky, Jonathan
    Macdonald, Erin M.
    Hollands, Simon
    Gomes, Tara
    Mamdani, Muhammad M.
    Paterson, J. Michael
    Lathia, Nina
    Juurlink, David N.
    [J]. PLOS MEDICINE, 2014, 11 (09)
  • [3] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    Lalmohamed, A.
    Souverein, P.
    Cooper, C.
    Veldt, B. J.
    Leufkens, H. G.
    de Boer, A.
    van Staa, T.
    de Vries, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 903 - 910
  • [4] Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study
    Chiu, Hui-Fen
    Huang, Ya-Wen
    Chang, Chih-Ching
    Yang, Chun-Yuh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (11) : 1131 - 1136
  • [5] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    S. Pouwels
    A. Lalmohamed
    P. Souverein
    C. Cooper
    B. J. Veldt
    H. G. Leufkens
    A. de Boer
    T. van Staa
    F. de Vries
    [J]. Osteoporosis International, 2011, 22 : 903 - 910
  • [6] Use of proton pump inhibitors and the risk of community-acquired pneumonia - A population-based case-control study
    Gulmez, Sinem Ezgi
    Holm, Anette
    Frederiksen, Henrik
    Jensen, Thoger Gorm
    Pedersen, Court
    Hallas, Jesper
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (09) : 950 - 955
  • [7] Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study
    Falhammar, Henrik
    Lindh, Jonatan D.
    Calissendorff, Jan
    Skov, Jakob
    Nathanson, David
    Mannheimer, Buster
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 59 : 65 - 69
  • [8] Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study
    Peng, Yen-Chun
    Lin, Cheng-Li
    Yeh, Hong-Zen
    Chang, Chi-Sen
    Wu, Yu-Lin
    Kao, Chia-Hung
    [J]. MEDICINE, 2016, 95 (15)
  • [9] Proton pump inhibitor use and risk of colorectal cancer: A population-based, case-control study
    Robertson, Douglas J.
    Larsson, Heidi
    Friis, Soren
    Pedersen, Lars
    Baron, John A.
    Sorensen, Henrik T.
    [J]. GASTROENTEROLOGY, 2007, 133 (03) : 755 - 760
  • [10] Proton pump inhibitor use associated with an increased risk of gout: A population-based case-control study
    Zhu, Kai-Jun
    Feng, Wei
    Ma, Xiao-Na
    Liao, Pei-Lun
    Lin, Chang-Song
    Huang, Jing-Yang
    Wei, James Cheng-Chung
    Xu, Qiang
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (09) : 1799 - 1806
12345